SCHEMBL29741744

SCHEMBL29741744

CCCCOC(=O)N1CCC(n2cnc(Nc3cc(Br)cn(C)c3=O)c2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK5 Q00535 6/20 0.38
▸ CDK5R1 Q15078 6/20 0.38
▸ CHRM2 P08172 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ NOS2 P35228 4/20 0.33
▸ NOS1 P29475 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HRH2 P25021 2/20 0.33
▸ HRH1 P35367 2/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ MMP3 P08254 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ MMP8 P22894 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ CALCRL Q16602 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14926052 0.84 PIK3CA (0.43) CDK5CDK5R1KDM4E
SCHEMBL29742089 0.79 SMN1; SMN2 (0.36) LMNAHRH2HRH1KDM4EHSD17B10
SCHEMBL29741933 0.78 BTK (0.42) —
SCHEMBL29742153 0.77 BTK (0.37) LMNA
SCHEMBL29742148 0.76 BTK (0.39) —
SCHEMBL14926055 0.76 WDR5 (0.41) CDK5CDK5R1
SCHEMBL29742005 0.76 BTK (0.40) LMNAHRH2HRH1
SCHEMBL29742104 0.73 SMN1; SMN2 (0.44) CDK5CDK5R1CHRM2CHRM1NOS2
SCHEMBL29925252 0.73 NAMPT (0.41) HRH2HRH1
SCHEMBL29742086 0.73 BTK (0.39) HRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4050012-A1 PYRIDONE BORONATES FOR THE PREPARATION OF INHIBITORS OF BTK ACTIVITY F. Hoffmann-La Roche AG (CH) 2022-08-31 — — EP disclosed
EP-4019508-A1 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY F. Hoffmann-La Roche AG (CH) 2022-06-29 — — EP disclosed
Send feedback